Skip to main content
SpringerLink
Log in

Immunobiology of Transplantation

  • Chapter
Book cover Hematopoietic Stem Cell Transplantation

Part of the book series: Contemporary Hematology ((CH))

  • 1377 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New England Journal of Medicine 1979;300(19):1068–73.

    PubMed  CAS  Google Scholar 

  2. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft versus host disease. Contribution of improved survival after allogeneic marrow transplantation. New England Journal of Medicine 1981;304:1529–33.

    PubMed  CAS  Google Scholar 

  3. Gale RP, Horowitz MM, Ash RC, et al. Identical-twin bone marrow transplants for leukemia. Annals of Internal Medicine 1994;120(8):646–52.

    PubMed  CAS  Google Scholar 

  4. Shizuru JA, NegrinRS, Weissman IL. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 2005;56:509–38.

    PubMed  CAS  Google Scholar 

  5. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58–62.

    PubMed  CAS  Google Scholar 

  6. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci, USA 1992;89:2804–8.

    PubMed  CAS  Google Scholar 

  7. Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ. Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci U S A 2005;102(52):19081–6.

    PubMed  CAS  Google Scholar 

  8. Linch DC, MilliganDW, Winfield DA, et al. G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. British Journal of Haematology 1997;99(4):933–8.

    PubMed  CAS  Google Scholar 

  9. BitMansour A, Cao TM, Chao S, Shashidhar S, Brown JM. Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. Blood 2005;105(9):3535–7. Epub 2004 Dec 2.

    PubMed  CAS  Google Scholar 

  10. Arber C, BitMansour A, Sparer TE, et al. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hemat-opoietic stem cell transplantation. Blood 2003;102(2):421–8. Epub 2003 Mar 27.

    PubMed  CAS  Google Scholar 

  11. Kagl D, LedermannB, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice [see comments]. Nature 1994;369:31–7.

    Google Scholar 

  12. Gumperz JE, Parham P. The enigma of the natural killer cells. Nature 1995;378: 245–8.

    PubMed  CAS  Google Scholar 

  13. Karre K. Express yourself or die: peptides, MHC molecules, and NK cells (comment).Science 1995;267:978–9.

    PubMed  CAS  Google Scholar 

  14. Colonna M, Dohring C, Samaridis J, et al. Human killer inhibitory receptors: specificity for HLA-class I molecules and mechanisms of signal transduction. Transplantation Proceedings 1996;28(6):3035.

    PubMed  CAS  Google Scholar 

  15. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097–100.

    PubMed  CAS  Google Scholar 

  16. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285(5428):727–9.

    PubMed  CAS  Google Scholar 

  17. Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999;285(5428):730–2.

    PubMed  CAS  Google Scholar 

  18. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3(10):781–90.

    PubMed  CAS  Google Scholar 

  19. Asai O, Longo DL,Tian ZG, et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Journal of Clinical Investigation 1998;101(9):1835–42.

    PubMed  CAS  Google Scholar 

  20. Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005;105(8):3051–7.

    PubMed  CAS  Google Scholar 

  21. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell allore-activity in mismatched hematopoietic transplants. Science 2002;295(5562):2097–100.

    PubMed  CAS  Google Scholar 

  22. Moretta L, Ferlazzo G, Bottino C, et al. Effector and regulatory events during natural killer-dendritic cellinteractions. Immunol Rev 2006;214:219–28.

    PubMed  CAS  Google Scholar 

  23. Weng WK, Levy R. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 2003;21(21):3940–7.

    PubMed  CAS  Google Scholar 

  24. Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753–63.

    PubMed  CAS  Google Scholar 

  25. Shilling HG, Young N, Guethlein LA, Cheng NW, Tyan D, Parham P. Genetic control of human NK cell repertoire. Journal of Immunology 2002;169:239–47.

    CAS  Google Scholar 

  26. Hart DNJ. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;90:3245–87.

    PubMed  CAS  Google Scholar 

  27. Engleman EG. Dendritic cells in the treatment of cancer. Biol Blood Marrow Transplantation 1996;2:115–7.

    CAS  Google Scholar 

  28. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002;20:621–67.

    PubMed  CAS  Google Scholar 

  29. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997;157:125–40.

    PubMed  CAS  Google Scholar 

  30. Warren EH, Gavin M, Greenberg PD, Riddell SR. Minor histocompatibility antigens as targets for T-celltherapy after bone marrow transplantation. Curr Opin Hematol 1998;5(6):429–33.

    PubMed  CAS  Google Scholar 

  31. Boismenu R, Havran WL. An innate view of gamma delta T cells. Current Opinion in Immunology 1997;9(1):57–63.

    PubMed  CAS  Google Scholar 

  32. Dulude G, Roy DC,Perreault C. The effect of graft-versus-host disease on T cell production and homeostasis. J Exp Med 1999;189(8):1329–42.

    PubMed  CAS  Google Scholar 

  33. van den Brink MR,Moore E, Ferrara JL, Burakoff SJ. Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation 2000;69(3):446–9.

    PubMed  Google Scholar 

  34. Min D, Taylor PA,Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002;99(12):4592–600.

    PubMed  CAS  Google Scholar 

  35. Bjorkman PJ, Davis MM. Model for the interaction of T-cell receptors with peptide/ MHC complexes. Cold Spring Harbor Symposia on Quantitative Biology 1989;54 Pt 1:365–73.

    PubMed  CAS  Google Scholar 

  36. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999;285(5426):412–5.

    PubMed  CAS  Google Scholar 

  37. Jenkins MK. The ups and downs of T cell costimulation. Immunity 1994;1:443–6.

    PubMed  CAS  Google Scholar 

  38. Guinan EC, Boussiotis VA, Neuberg D, et al. Transplantation of anergic histoin-compatible bone marrow allografts. N Engl J Med 1999;340(22):1704–14.

    PubMed  CAS  Google Scholar 

  39. Vincenti FG, Luggen M. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annu Rev Med 2006.

    Google Scholar 

  40. Lanzavecchia A. Licence to kill. Nature 1998;393:413–4.

    PubMed  CAS  Google Scholar 

  41. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335–76.

    PubMed  CAS  Google Scholar 

  42. Cobleigh MA, Vogel CL, Tripathy D, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. Journal of Clinical Oncology 1999;17(9):2639–48.

    PubMed  CAS  Google Scholar 

  43. Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histo-compatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005;105(7):2973–8.

    PubMed  CAS  Google Scholar 

  44. Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006;108(2):756–62.

    PubMed  CAS  Google Scholar 

  45. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med 2006;354(11):1166–76.

    PubMed  CAS  Google Scholar 

  46. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annual Review of Immunology 1997;15(1):535–62.

    PubMed  CAS  Google Scholar 

  47. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2006.

    Google Scholar 

  48. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. Journal of Immunology 1999;162(11):6410–9.

    CAS  Google Scholar 

  49. Lan F, Zeng D, Higuchi M, Higgins JP, Strober S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant 2003;9(6):355–63.

    PubMed  Google Scholar 

  50. Lowsky R, Takahashi T, Liu YP, et al. Protective conditioning for acute graft-ver-sus-host disease. N Engl J Med 2005;353(13):1321–31.

    PubMed  CAS  Google Scholar 

  51. Ng WF, Duggan PJ, Ponchel F, et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001;98(9):2736–44.

    PubMed  CAS  Google Scholar 

  52. Hoffmann R, Ermann J, Edinger M, Fathman CG, Strober S. Donor type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. Journal of Experimental Medicine 2002;196:389–99.

    PubMed  CAS  Google Scholar 

  53. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99(10):3493–9.

    PubMed  CAS  Google Scholar 

  54. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002;196(3):401–6.

    PubMed  CAS  Google Scholar 

  55. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299(5609):1057–61. Epub 2003 Jan 9.

    PubMed  CAS  Google Scholar 

  56. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003;112(9):1437–43.

    PubMed  CAS  Google Scholar 

  57. Edinger M, Hoffmann P, Ermann J, et al. CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003;9:1144–50.

    PubMed  CAS  Google Scholar 

  58. Trenado A, Charlotte F, Fisson S, et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003;112(11):1688–96.

    PubMed  CAS  Google Scholar 

  59. Zorn E, Kim HT, Lee SJ, et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005;106(8):2903–11.

    PubMed  CAS  Google Scholar 

  60. Rezvani K, Mielke S, Ahmadzadeh M, et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006;108(4):1291–7.

    PubMed  CAS  Google Scholar 

  61. Ploegh HL. Viral strategies of immune evasion. Science 1998;280(5361): 248–53.

    PubMed  CAS  Google Scholar 

  62. Bennett MW, O'Connell J, O'Sullivan GC, et al. The Fas counterattack in vivo: apoptotic depletion of tumor- infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 1998;160(11):5669–75.

    PubMed  CAS  Google Scholar 

  63. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996;184(3):1075–82.

    PubMed  Google Scholar 

  64. Leen AM, Rooney CM, Foster AE. Improving T Cell Therapy for Cancer. Annu Rev Immunol 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Stanford University, Stanford, CA

    Robert S. Negrin

Authors
  1. Robert S. Negrin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Hematologic Malignancies, Dana-Farber Cancer Institute, 44 Binney Street, DFCI D1B30, Boston, MA, 02115, USA

    Robert J. Soiffer MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Negrin, R.S. (2008). Immunobiology of Transplantation. In: Soiffer, R.J. (eds) Hematopoietic Stem Cell Transplantation. Contemporary Hematology. Humana Press. https://doi.org/10.1007/978-1-59745-438-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-438-4_3

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-05-3

  • Online ISBN: 978-1-59745-438-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation